| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |